About Tirzepatide
Tirzepatide is a dual-action GLP-1/GIP receptor agonist approved by the FDA for treating type 2 diabetes (Mounjaro®) and weight management (Zepbound®). These FDA-approved products have undergone rigorous testing for safety and effectiveness.
IMPORTANT: Sprout Health offers compounded tirzepatide, which is NOT the same as FDA-approved products.
What this means:
- Compounded tirzepatide is prepared by state-licensed pharmacies for individual patients
- It has not been approved by the FDA
- The FDA does not verify the safety, effectiveness, or quality of compounded tirzepatide
- Compounded tirzepatide should only be used when FDA-approved medications cannot meet your specific medical needs
Compounded medications are prepared under state and federal regulatory oversight and must adhere to established safety and quality standards.
How Does Tirzepatide Work?
Tirzepatide activates both GLP-1 and GIP receptors, two hormones involved in blood sugar regulation and appetite control. This dual mechanism may offer:
- Reduced appetite and food intake
- Improved blood sugar regulation
- Slower gastric emptying, helping you feel full longer
When Compounded Tirzepatide May Be Appropriate
Your provider may determine that compounded tirzepatide is appropriate if:
- You have a documented allergy to inactive ingredients in FDA-approved tirzepatide products
- You require a dosage strength not commercially available in FDA-approved products
- You have specific formulation requirements not available in FDA-approved products
Cost alone is not sufficient justification for compounding. During your medical evaluation, your licensed provider will determine whether an FDA-approved tirzepatide product can meet your needs or if you have specific medical circumstances requiring compounded tirzepatide.
FDA-Approved Alternatives
FDA-approved tirzepatide products (Mounjaro® and Zepbound®) are available through traditional healthcare providers and pharmacies. If you are interested in an FDA-approved option, discuss this with your clinician.
Common Side Effects
Side effects may include but are not limited to:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Abdominal pain
- Injection site reactions
This is not a complete list of side effects. Discuss potential risks and side effects with your clinician. If you experience severe or concerning symptoms, contact your clinician immediately or seek emergency medical care.
Reporting Adverse Events
If you experience an adverse event or product quality issue, you can report it to:
- Your clinician through the medical portal
- FDA MedWatch: www.fda.gov/medwatch or 1-800-FDA-1088
- Your compounding pharmacy (see “Compounding Pharmacy Information”)